Deadline Approaching for LifeMD, Inc. Class Action Lawsuit: Investors Alerted by Berger Montague

LifeMD Class Action Lawsuit: Important Information for Investors

As the deadline approaches on October 27, 2025, Berger Montague, a national plaintiffs' law firm, is urging investors of LifeMD, Inc. (NASDAQ: LFMD) to inquire about a significant securities fraud lawsuit. This lawsuit came to light after LifeMD was accused of misleading investors regarding its financial status and business outlook.

Overview of the Lawsuit

The class action lawsuit against LifeMD has been filed on behalf of investors who acquired shares during the period from May 7, 2025, to August 5, 2025. The allegations center around the claim that LifeMD issued materially false and/or misleading statements about its competitive position and financial forecasts. Specifically, the lawsuit contends that the company over-inflated its growth expectations, particularly within its RexMD segment, which focuses on providing telehealth services and obesity-related medications such as Wegovy and Zepbound.

The lawsuit highlights that LifeMD did not properly account for increasing customer acquisition costs, which ultimately misled investors about the company's actual market performance. When the reality was revealed, the company’s stock plummeted by 44%, resulting in a loss of $5.31 per share in a single day, causing significant concern among investors.

How to Participate

Investors who purchased or acquired LifeMD securities during this specified period are invited to take action by no later than the deadline. By contacting Berger Montague, they can seek to be appointed as a lead plaintiff representative in the class action. This is crucial for those who wish to assert their rights and potentially recover losses.

To learn more about your rights as a shareholder and the possibility of joining the lawsuit, interested parties can reach out directly to Andrew Abramowitz at Berger Montague via email or phone at (215) 875-3015, or to Caitlin Adorni at (267) 764-4865. Both can provide additional details on how to proceed with a claim.

About LifeMD

Headquartered in New York, LifeMD is known for offering telehealth services that enable direct patient consultations and pharmacy services. Their business model, which includes evolving products aimed at healthcare and wellness, has seen notable interest, however, the recent allegations have cast a shadow on its perceived stability and reliability.

Conclusion

As the deadline approaches, all affected investors are encouraged to act swiftly. The securities fraud lawsuit involving LifeMD, Inc. serves as a reminder of the importance of investor vigilance and due diligence, particularly in a market environment fraught with complexities and potential misleading corporate behavior.

For up-to-date information, investors should remain engaged with their legal representatives and stay informed through reliable financial news channels. Berger Montague has been a key advocate for investor rights for decades, focusing on holding companies accountable for any misleading or harmful practices.

For any further inquiries or to discuss this matter, Berger Montague remains available to assist investors in navigating the complexities of this class action lawsuit.